(18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib.
Benz MR; Herrmann K; Walter F; Garon EB; Reckamp KL; Figlin R; Phelps ME; Weber WA; Czernin J; Allen-Auerbach MS; Journal Of Nuclear Medicine: Official Publication, Society Of Nuclear Medicine, 2011, vol. 52, issue 11, p 1684, ISSN 15355667. ISBN 15355667.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef